| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.006 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.5 | 0.008 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |